MedPath

IRBESARTAN PENSA 300 mg COMPRIMIDOS EFG

IRBESARTAN PENSA 300 mg COMPRIMIDOS EFG

Commercialized
Register Number

72191

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Apr 28, 2010

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number72191
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

IRBESARTANActive
Quantity: 300,0 mg
Name: IRBESARTAN

ATC CLASSIFICATION (3)

C09C
C09CA
C09CA04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.